1. Lima RT, Sousa D, Paiva AM, Palmeira A, Barbosa J, Pedro M, Pinto MM, Sousa E, Vasconcelos MH

Modulation of Autophagy by a Thioxanthone Decreases the Viability of Melanoma Cells. Molecules (Basel, Switzerland) 21: 1343, 2016. [Article] 

 doi: 10.3390/molecules21101343 PMID: 27735867.

 

2. Lima RT, Barron GA, Grabowska JA, Bermano G, Kaur S, Roy N, Helena Vasconcelos M, Lin PK

Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line. Anti-cancer agents in medicinal chemistry 13: 414-21, 2013. [Article] 

 PMID: 23092269.

 

3. Lima RT, Seca H, Palmeira A, Fernandes MX, Castro F, Correia-da-Silva M, Nascimento MS, Sousa E, Pinto M, Vasconcelos MH

Sulfated small molecules targeting eBV in Burkitt lymphoma: from in silico screening to the evidence of in vitro effect on viral episomal DNA. Chemical biology & drug design 81: 631-44, 2013. [Article] 

 doi: 10.1111/cbdd.12109 PMID: 23350710.

 

4. Lima Raquel T., Nascimento M . S. José, Vasconcelos M. Helena

EBV-associated cancers: Strategies for targeting the virus Microbial pathogens and strategies for combating them: science, technology and education 3: 1608-1618, 2013. [] 

.

 

5. Lima RT, Seca H, Brás S, Nascimento MS, Vasconcelos MH

Treatment of Akata EBV-positive cells with doxorubicin causes more EBV reactivation than treatment with etoposide. Chemotherapy 57: 195-203, 2011. [Article] 

 doi: 10.1159/000323627 PMID: 21540588.

 

6. Lima RT, Seca H, Soares P, Nascimento MS, Vasconcelos MH

EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide. Journal of cellular biochemistry 112: 200-10, 2011. [Article] 

 doi: 10.1002/jcb.22920 PMID: 21069730.

 

7. Lima R T, Guimarães JE, Vasconcelos MH

Overcoming K562Dox resistance to STI571 (Gleevec) by downregulation of P-gp expression using siRNAs Cancer Therapy 5: 67-76, 2007. [] 

.

 

8. Lima RT, Martins LM, Guimarães JE, Sambade C, Vasconcelos MH

Chemosensitization effects of XIAP downregulation in K562 leukemia cells. Journal of chemotherapy (Florence, Italy) 18: 98-102, 2006. [Article] 

 PMID: 16572900.

 

9. Lima RT, Martins LM, Guimarães JE, Sambade C, Vasconcelos MH

Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer gene therapy 11: 309-16, 2004. [Article] 

 doi: 10.1038/sj.cgt.7700706 PMID: 15031723.

 

1. Príncipe C, Dionísio de Sousa IJ, Prazeres H, Soares P, Lima RT

LRP1B: A Giant Lost in Cancer Translation. Pharmaceuticals (Basel, Switzerland) 14: ., 2021. [Review] 

 doi: 10.3390/ph14090836 PMID: 34577535.

 

2. Dionísio de Sousa IJ, Cunha AI, Saraiva IA, Portugal RV, Gimba ERP, Guimarães M, Prazeres H, Lopes JM, Soares P, Lima RT

LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer. Pathobiology : journal of immunopathology, molecular and cellular biology 88: 400-411, 2021. [Article] 

 doi: 10.1159/000517372 PMID: 34689147.

 

3. Bizarro A, Ferreira IC, Sokovic M, van Griensven LJ, Sousa D, Vasconcelos MH, Lima RT

Cordyceps militaris (L.) Link Fruiting Body Reduces the Growth of a Non-Small Cell Lung Cancer Cell Line by Increasing Cellular Levels of p53 and p21. Molecules (Basel, Switzerland) 20: 13927-40, 2015. [Article] 

 doi: 10.3390/molecules200813927 PMID: 26263965.